Table 1

Baseline data of sub-study participants (HIV-negative at enrolment) expressed as numbers (%) or mean values (SD]

All participants with HIV-negative status at baselineParticipants with follow-up
IPC group (N=878)IUD group (N=874)IPC group (N=656)IUD group (N=634)
Characteristicn (%) or mean [SD]Nn (%) or mean [SD]Nn (%) or mean [SD]Nn (%) or mean [SD]N
Age (years)25.7 [6.2]87326.0 [6.3]86726.0 [6.3]65526.0 [6.3]631
Weight (kg)69.9 [16.3]86071.2 [18.2]85370.3 [16.2]64471.9 [18.2]615
Previous miscarriage76 (8.7)87885 (9.7)87466 (10.1)65668 (10.7)634
Previous caesarean section98 (11.2)878112 (12.8)87472 (11.0)65676 (12.0)634
Previous pelvic sepsis*162 (18.5)878170 (19.5)874120 (18.3)656170 (19.5)634
Hypertension4 (0.5)8785 (0.6)8742 (0.3)6563 (0.5)634
Diabetes mellitus1 (0.1)8783 (0.3)8741 (0.1)6563 (0.5)634
Previous contraception use
 IPC565 (71.7)788562 (71.4)787438 (75)586425 (75)566
 OC48 (5.8)83064 (7.7)82732 (5.2)61644 (7.4)598
 IUD1 (0.1)8301 (0.1)8271 (0.1)6161 (0.1)598
  • *South Africa implements the World Health Organization Primary Care model whereby women with certain signs and symptoms are treated ‘syndromically’ for assumed pelvic infection. This may result in over-diagnosis.

  • IPC, injectable progestogen contraception; IUD, intrauterine device; OC, oral contraception; SD, standard deviation.